The following table provides an overview of the latest patents of University Of Washington Through Its Center For Commercialization that has been opposed by its competitors. It provides an insight into the competitive landscape of the industry and highlights the patents that are subject to oppositions.

Patent NumberGrant DateTitleTotal Oppositions
EP2838548Jul 19, 2023Hla Class Ii Deficient Cells, Hla Class I Deficient Cells Capable Of Expressing Hla Class Ii Proteins, And Uses Thereof2
EP2828218Apr 7, 2021Methods Of Lowering The Error Rate Of Massively Parallel Dna Sequencing Using Duplex Consensus Sequencing3
EP2699593Nov 4, 2020Beta-2 Microglobulin-Deficient Cells1